Core Viewpoint - Company Jiukang Bio (300406.SZ) has received a medical device registration certificate from the Beijing Drug Administration for three products, enhancing its product line in the in vitro diagnostic sector [1] Group 1: Product Registration - The products that received registration include "D-Dimer Calibration Product," "Calcitonin Assay Kit (Magnetic Particle Chemiluminescence Immunoassay)," and "Mycophenolic Acid Assay Kit (IMPDH II Method)" [1] - The acquisition of these medical device registration certificates enriches the company's offerings in the fields of biochemical diagnostics, chemiluminescence, and coagulation [1] Group 2: Impact on Company - The new product registrations are expected to enhance the company's core competitiveness and market expansion capabilities [1] - The developments are anticipated to have a positive impact on the company's future operations [1]
九强生物(300406.SZ)取得三项医疗器械注册证书